Tamayo MK, Velázquez ÁY

Language: Spanish
References: 14
Page: 1-11
PDF size: 425.46 Kb.

ABSTRACT

Introduction: Chronic actinic damage is a group of alterations in the structure, function and appearance of the skin as a result of prolonged and uncontrolled exposure to ultraviolet radiation, other radiation and the use of inadequate sun protection, which can lead to skin carcinomas.
Objective: To characterize patients with chronic actinic damage seen in Dermatology consultation in the province of Las Tunas.
Methods: A descriptive, cross-sectional, observational study was carried out in a sample of 1720 patients diagnosed with chronic actinic damage, in the period from December 2019 to June 2020. The variables age, gender, skin color, skin phototype, occupation, use of sunscreen and sunscreen according to skin type, exposure to radiation and clinical characteristics of photodamage lesions were evaluated. The information obtained was presented in tables and statistical graphs and for the description the variables are shown in percentages.
Results: The predominance of the age group 25-59 years (70.9%) without significant influence of gender, higher incidence of white skin color (98.8%), skin phototype II (64.1%) and government workers (65.1%). A 74.8% of the patients frequently use some type of sun protection, 25.2% do not use it. 99.8% were not exposed to other types of radiation.
Photodamage lesions were actinic keratoses (71.2%) and solar lentigo (7.3%). Conclusions: The predominant clinical manifestation of photodamage was actinic keratosis. Most of the patients did not use sunscreen and those who did, did not use it according to their skin type or recommended frequency. Most of the population studied reported using at least some type of protection.

REFERENCES

1. Bernabéu A. La necesaria fotoprotección. Farmacéutica. 2007 [acceso 08/07/2020];26(5).Disponible en: https://www.elsevier.es/es-revista-offarm-4-pdf-13102414

2. Latina P. Una forma de vitamina B3 reduce el riesgo de cáncer de piel. Boletin de PrensaAl Día. 2015 [acceso 23/07/2020]. Disponible en:https://boletinaldia.sld.cu/aldia/2015/05/15/una-forma-de-vitamina-b3-reduce-el-riesgo-decancer-de-piel/

3. Puericultura CRNd. Estrategia para la atención de niños y adolescentes con Daño ActínicoCrónico. Cuba: 2008-2013 [acceso 23/07/2020]. Disponible en:https://temas.sld.cu/puericultura/2011/12/30/estrategia-para-la-atencion-de-ninos-yadolescentes-con-dano-actinico-cronico-cuba/

4. James E, Fitzpatrick W. Urgencias dermatológicas Diagnóstico Sintomático. Barcelona:Elsevier Inc.; 2018. p. 97.

5. James WDE, Dirk M, James R, Rosenbach Misha A, Neuhaus Isaac M. Andrews' Diseasesof the Skin. 13th ed. New York: Elsevier Inc.; 2019.

6. Russo S. Summer sun-exposure in Australian childhood cancer survivors and communityreference groups. Semin Oncol. 2020;22.

7. González F, Mireille J, Chávez B. Terapia fotodinámica con luz de día en el tratamientode la queratosis actínica y el campo de cancerización: recomendaciones de consenso paraAmérica Latina. Piel. 2017;32(3):142-9.

8. FitzPatrick W. Atlas de Dermatología Clinica. 7 ed. Dusseldorf: Elsevier; 2013.

9. Siegel JA, Korgavkar K, Weinstock MA. Current perspective on actinic keratosis: areview. Br J Dermatol. 2017;177(2):350-8.

10. Arenas R. Atlas de Dermatología. Diagnóstico y Tratamiento. 3 ed. México:McGrawHill; 2008.

11. Vila-Payeras EA. Evaluación de la tasa de detección incidental de cáncer cutáneo: estudioprospectivo en un servicio hospitalario. Actas Dermosifiliográficas. 2020 [acceso23/07/2020]. Disponible en: www.actasdermo.org

12. Millan-Cayetano J. ¿Cómo debe realizarse el seguimiento de los pacientes tratados convemurafenib? Piel. 2017;32:123-5.

13. Luis Requena CR. Proliferaciones y tumores epidérmicos benignos. En: Elsevier, editor.Dermatología. 4 ed. España: Elsevier; 2019. p. 1894-916.

14. Ferrándiz MJ, Guillén C, Ferrándiz-Pulido C, Fernández-Figueras MT. PrecancerousSkin Lesions. Actas dermosifiliográficas. 2017 [acceso 23/07/2020];108:31-41. Disponibleen: www.actasdermo.org